Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology

Aug 06, 2026

Posted by Pharvaris, Inc.

Altruist Biologics Completes First Commercial PPQ Campaign of its 20,000L Production Line at the Hangzhou Site

Aug 05, 2026

Posted by Altruist Biologics

National Comprehensive Cancer Network Foundation Introduction

Aug 03, 2026

Posted by National Comprehensive Cancer Network Foundation (NCCNF)

RENTSCHLER BIOPHARMA – Outsourced Pharma Capabilities Update: Large Molecule/Our Site in Milford, MA

Jul 28, 2026

Posted by Rentschler Biopharma Inc

Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema

Jul 22, 2026

Posted by Pharvaris, Inc.

Now On Demand: From Preclinical to First-in-Human Live Q&A

Jul 21, 2026

Posted by tranScrip